<DOC>
	<DOCNO>NCT00620542</DOCNO>
	<brief_summary>A 104-week , randomize , double-blind , parallel group , multi-center Phase IIIb study compare effect treatment rosuvastatin 40 mg atorvastatin 80 mg atherosclerotic disease burden measure intravascular ultrasound patient coronary artery disease .</brief_summary>
	<brief_title>CRESTOR Athero Imaging Head Head IVUS Study</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Clinical indication coronary angiography Angiographic evidence Coronary Artery Disease ( CAD ) , define least 1 lesion native coronary artery &gt; 20 % reduction lumen diameter visual estimation Left main coronary artery must &lt; =50 % reduction lumen diameter visual estimation LDLC &gt; 100 mg/dL ( 2.6 mmol/L ) patient statin therapy past 4 week ; LDLC &gt; 80mg/dL ( 2.08mmol/L ) patient therapy past 4 week Use certain lipidlowering medication 3 month within previous 12 month . Longer period treatment permit potential effect therapy coronary atherosclerosis . Patients symptoms consistent moderate great severity Congestive Heart Failure ( CHF ) . Clinically significant heart disease , opinion Principal Investigator ( designee ) , likely require coronary bypass surgery , cardiac transplantation , surgical repair and/or replacement course study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Coronary artery disease</keyword>
</DOC>